Transactions
11
Insider / NATIONAL HEALTH INVESTORS INC
SWAFFORD CHARLOTTE A
Director at NATIONAL HEALTH INVESTORS INC
- Ticker
- NHI
- First filing on record
- December 11, 2025
- Latest trade on record
- December 9, 2025
- SEC filings
- EDGAR ↗
SWAFFORD CHARLOTTE A, Director at NATIONAL HEALTH INVESTORS INC, has disclosed 11 transactions in NHI since December 11, 2025: 0 purchases (0 open-market buys) and 1 sale, worth about $9.8M at the reported prices. The latest was filed December 11, 2025, 2 days after the trade.
Open-market buys
0
Sales
1
Avg. disclosure lag
2.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months SWAFFORD CHARLOTTE A made no purchases and 1 sale worth $4.9M, plus 10 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
SWAFFORD CHARLOTTE A has traded 1 stock on record; the largest by dollars is NHI.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 10 | 160,000 | $4.9M |
| F | Shares withheld for tax | 1 | 62,827 | $4.9M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2025 | 11 | 0 | 1 · $4.9M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 10,000 | — | — | derivative | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 10,000 | — | — | derivative | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 10,000 | — | — | derivative | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 25,000 | — | — | derivative | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 25,000 | — | — | derivative | Form 4 ↗ | |
| NHI | Sell F | December 9, 2025 | December 11, 2025 | 2d | 62,827 | $78 | $4.9M | indirect | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 10,000 | $73 | $733K | indirect | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 10,000 | $58 | $578K | indirect | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 10,000 | $55 | $547K | indirect | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 25,000 | $53 | $1.3M | indirect | Form 4 ↗ | |
| NHI | Option / conversion M | December 9, 2025 | December 11, 2025 | 2d | 25,000 | $69 | $1.7M | indirect | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| December 11, 2025 | Form 4 | 0000877860-25-000194 | 11 | published | EDGAR ↗ |
Other insiders at NATIONAL HEALTH INVESTORS INC
- Mendelsohn D. Eric CEO and President 22 rows
- Travis David L SVP/Chief Accounting Officer 21 rows
- Spaid John L CFO/EVP Finance 17 rows
- PASCOE KEVIN CARLTON Chief Investment Officer 12 rows
- Jobe James R Director 8 rows
- MCCABE ROBERT A JR Director 8 rows
- Gaines Kristin Sallee SVP/Chief Transaction Officer 7 rows
- ADAMS ROBERT G Director 5 rows
- COLDEN TRACY M J Director 4 rows
- Todd Candice W Director 4 rows
Everyone on file, with contracts and lobbying under the company's name: NATIONAL HEALTH INVESTORS INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 11 | December 11, 2025 | December 11, 2025 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.